MRE Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| Line 17: | Line 17: | ||
'''''[[MRE BC Call Summaries Archive]]''''' | '''''[[MRE BC Call Summaries Archive]]''''' | ||
==MRE Profile Development== | ==MRE Profile Development== | ||
*[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf|'''MRE Profile, Draft: July 28, 2017''']] | *[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf|'''MRE Profile, Draft: July 28, 2017''']] | ||
*[[Media:Draft-MRE-QIBAProfile-2017-07-06.pdf|''MRE Profile, Initial Draft: July 6, 2017'']] | *[[Media:Draft-MRE-QIBAProfile-2017-07-06.pdf|''MRE Profile, Initial Draft: July 6, 2017'']] | ||
==Working Documents== | ==Working Documents== | ||
Revision as of 21:29, 12 December 2017
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- Secretary: Susan Weinmann
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries: